Ayala Pharmaceuticals SG&A Expense (Quarterly) Trends

Ayala Pharmaceuticals Inc (ADXS)

0.555 +0.02 (+4.62%) USD | OTCM | May 03, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	3.37M
September 30, 2023	1.448M
June 30, 2023	2.763M
December 31, 2022	2.156M
September 30, 2022	2.881M
June 30, 2022	2.272M
March 31, 2022	2.441M
December 31, 2021	2.24M
September 30, 2021	2.198M
June 30, 2021	2.536M

Date	Value
March 31, 2021	2.303M
December 31, 2020	2.652M
September 30, 2020	1.862M
June 30, 2020	1.546M
March 31, 2020	1.311M
December 31, 2019	1.522M
September 30, 2019	0.945M
June 30, 2019	1.021M
March 31, 2019	0.848M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.945M

Minimum

Sep 2019

3.37M

Maximum

Dec 2023

2.082M

Average

2.219M

Median

SG&A Expense (Quarterly) Benchmarks